Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Part I

• Main Authors: I Ye Chazova, S A Tyulyandin, M V Vitsenia, A G Ovchinnikov, M G Poltavskaya, M Yu Gilyarov, T V Martynyuk, E P Panchenko, Yu A Fedotkina, M B Stenina, O P Trophimova, F T Ageev
• Format: Article
• Language: Russian
• Published: IP Morozov P.V. 2017-12-01
• Series: Системные гипертензии
• Subjects: cardiotoxicity; chemotherapy; anthracyclines; trastuzumab; left ventricular dysfunction; heart failure; diagnosis; prevention; treatment
• Online Access: https://syst-hypertension.ru/2075-082X/article/viewFile/29580/pdf
• ISSN: 2075-082X; 2542-2189

Advances in treatment have led to improved survival of patients with cancer but have also resulted in untoward side effects associated with treatment. Cardiovascular diseases are one of the most frequent of these side effects. Myocardial dysfunction and heart failure, myocardial ischaemia, arrhythmias, arterial hypertension, thromboembolic disease and other cardiovascular complications can interfere with the efficacy of treatment, decrease quality of life, or impact the actual survival of the patient with cancer. This manual discusses concepts for timely diagnosis, intervention, and surveillance of patients treated with cardiotoxic cancer therapies. In this first part оf manual we discuss the diagnostic, prevention and treatment aspects of cancer therapy-related cardiac dysfunction and heart failure.